221 related articles for article (PubMed ID: 23791386)
21. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
22. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
[TBL] [Abstract][Full Text] [Related]
23. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
24. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening].
Mateos ML; Chacón de Antonio J; Rodríguez-Domínguez M; Sanz I; Rubio MD
Enferm Infecc Microbiol Clin; 2011; 29(6):411-4. PubMed ID: 21435749
[TBL] [Abstract][Full Text] [Related]
27. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
28. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
Isidean SD; Coutlée F; Franco EL
Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
[TBL] [Abstract][Full Text] [Related]
29. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
[TBL] [Abstract][Full Text] [Related]
30. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Yu S; Kwon MJ; Lee EH; Park H; Woo HY
J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
[TBL] [Abstract][Full Text] [Related]
32. Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
Jung S; Lee B; Lee KN; Kim Y; Oh EJ
Arch Pathol Lab Med; 2016 Mar; 140(3):276-80. PubMed ID: 26927723
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
Carozzi FM; Burroni E; Bisanzi S; Puliti D; Confortini M; Giorgi Rossi P; Sani C; Scalisi A; Chini F
J Clin Microbiol; 2011 Apr; 49(4):1446-51. PubMed ID: 21325553
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.
Safaeian M; Herrero R; Hildesheim A; Quint W; Freer E; Van Doorn LJ; Porras C; Silva S; González P; Bratti MC; Rodriguez AC; Castle P;
J Clin Microbiol; 2007 May; 45(5):1447-54. PubMed ID: 17344361
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic.
Keegan H; Pilkington L; McInerney J; Jeney C; Benczik M; Cleary S; von Bunau G; Turner M; D'Arcy T; O' Toole S; Pal-Szenthe B; Kaltenecker B; Mózes J; Kovács A; Solt A; Bolger N; O'Leary J; Martin C
J Virol Methods; 2014 Jun; 201():93-100. PubMed ID: 24583109
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.
Kang WD; Kim CH; Cho MK; Kim JW; Kim YH; Choi HS; Kim SM
Int J Gynecol Cancer; 2009 Jul; 19(5):924-8. PubMed ID: 19574786
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Park Y; Lee E; Choi J; Jeong S; Kim HS
J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population.
Wong OG; Lo CK; Szeto E; Cheung AN
J Clin Virol; 2011 Jun; 51(2):136-8. PubMed ID: 21530385
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Abbott RealTime High-Risk HPV and Hybrid Capture 2 Assays for Detection of HPV Infection.
Ko K; Yu S; Lee EH; Park H; Woo HY; Kwon MJ
Ann Clin Lab Sci; 2016 Sep; 46(5):522-8. PubMed ID: 27650620
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
